Houston Methodist among largest providers of monoclonal antibody treatment for COVID-19

(Houston Methodist) Among the nation's largest providers of monoclonal antibodies for Covid-19, Houston Methodist has infused nearly 4,000 patients. The hospital system was able to quickly ramp up its program by leveraging numerous resources through interdisciplinary collaboration. A commentary outlining challenges, resources and benchmarks published online March 29 in the New England Journal of Medicine Catalyst and serves as a valuable model as more hospitals begin to treat Covid-19 with mAB t...